Literature DB >> 6330487

Hydrocarbon transport in chylomicrons and high-density lipoproteins in rat.

A Vost, N Maclean.   

Abstract

A lipoprotein system is described that transports gut hydrocarbons of low polarity in chylomicrons of intestinal lymph and plasma to plasma high density lipoproteins (HDL) in rat. Four highly lipophilic aryl and alkyl hydrocarbons [benzo(alpha)pyrene; 1,1,1-trichloro-2,2-bis(p-chlorophenol)ethane (DDT), hexadecane and octadecane] were selected to give a graded range of polarity. Chylomicrons were labeled doubly with radioisotopes in triacylglycerol and a single hydrocarbon by feeding [3H]-glycerol and [14C]hydrocarbon. All hydrocarbons were transported in the triacylglycerol oil phase of chylomicrons. Injected chylomicron triacylglycerol and 3 of 4 hydrocarbons were cleared simultaneously from plasma consistent with lipoprotein-lipase dependent hydrocarbon clearance but DDT was cleared more rapidly. HDL was the major plasma acceptor of all labelled hydrocarbons. Plasma chemical fluxes were measured for octadecane and DDT and both showed net fluxes from chylomicrons to HDL. HDL selectively concentrated chylomicron hydrocarbons from chylomicron triacylglycerol. Lipoprotein lipase stimulation by intravenous heparin significantly increased transfer of alkanes from chylomicrons to HDL. These results indicate that (a) chylomicrons transport gut-derived hydrocarbons with a wide range of structure and polarity as triacylglycerol solutes; (b) HDL are a major plasma acceptor of all these hydrocarbons, demonstrating both selective solute uptake from triacylglycerol and net chemical uptake for the 2 hydrocarbons studied and (c) efflux of these chylomicron hydrocarbons from plasma and into HDL is regulated partly by hydrolysis of chylomicron triacylglycerol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330487     DOI: 10.1007/bf02537404

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  42 in total

1.  [Enzymic method for the determination of glycerin].

Authors:  O WIELAND
Journal:  Biochem Z       Date:  1957

2.  Separation of mammalian neutral lipids by chromatography on glass-fiber paper impregnated with silica gel.

Authors:  D M Pocock; S Rafal; A Vost
Journal:  J Chromatogr Sci       Date:  1972-02       Impact factor: 1.618

3.  Transport of orally administered 9,10-dimethyl-1,2-benzanthracene in the Sprague-Dawley rat.

Authors:  C J Grubbs; R C Moon
Journal:  Cancer Res       Date:  1973-07       Impact factor: 12.701

Review 4.  Vitamin E.

Authors:  J G Bieri; P M Farrell
Journal:  Vitam Horm       Date:  1976       Impact factor: 3.421

5.  Serum and tissue distribution of benzol[a]pyrene from intravenously injected chylomicrons in rat in vivo.

Authors:  M Vauhkonen; T Kuusi; P K Kinnunen
Journal:  Cancer Lett       Date:  1980-12       Impact factor: 8.679

6.  Hydrocarbons and polychlorinated biphenyls from the unsaponifiable fraction of anhydrous milk fat.

Authors:  V P Flanagan; A Ferretti
Journal:  J Lipid Res       Date:  1973-05       Impact factor: 5.922

7.  Chylomicron remnant cholesteryl esters as the major constituent of very low density lipoproteins in plasma of cholesterol-fed rabbits.

Authors:  A C Ross; D B Zilversmit
Journal:  J Lipid Res       Date:  1977-03       Impact factor: 5.922

8.  Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions.

Authors:  M Burstein; H R Scholnick; R Morfin
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

9.  Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons.

Authors:  T G Redgrave
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

10.  Uptake and metabolism of circulating chylomicron triglyceride by rabbit aorta.

Authors:  A Vost
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922

View more
  9 in total

1.  Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism.

Authors:  Natalie L Trevaskis; David M Shackleford; William N Charman; Glenn A Edwards; Anne Gardin; Silke Appel-Dingemanse; Olivier Kretz; Bruno Galli; Christopher J H Porter
Journal:  Pharm Res       Date:  2009-03-12       Impact factor: 4.200

Review 2.  Adipose Tissue as a Site of Toxin Accumulation.

Authors:  Erin Jackson; Robin Shoemaker; Nika Larian; Lisa Cassis
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

3.  Fate of 7,12-dimethylbenz(a)anthracene absorbed from the rat intestine and transported in chylomicrons.

Authors:  M B Lindstrom; J A Barrowman; B Borgstrom
Journal:  Lipids       Date:  1987-04       Impact factor: 1.880

4.  Distribution of toxaphene, DDT, and PCB among lipoprotein fractions in rat and human plasma.

Authors:  A Mohammed; A Eklund; A M Ostlund-Lindqvist; P Slanina
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

Review 5.  Factors affecting the storage and excretion of toxic lipophilic xenobiotics.

Authors:  R J Jandacek; P Tso
Journal:  Lipids       Date:  2001-12       Impact factor: 1.880

6.  Rapid clearance of hexachlorobenzene from chylomicrons.

Authors:  Ronald J Jandacek; Shuqin Zheng; Qing Yang; Patrick Tso
Journal:  Lipids       Date:  2004-10       Impact factor: 1.880

7.  The transport of DDT from chylomicrons to adipocytes does not mimic triacylglycerol transport.

Authors:  Alison B Kohan; Abbey E Vandersall; Qing Yang; Min Xu; Ronald J Jandacek; Patrick Tso
Journal:  Biochim Biophys Acta       Date:  2012-08-03

Review 8.  Toxicological function of adipose tissue: focus on persistent organic pollutants.

Authors:  Michele La Merrill; Claude Emond; Min Ji Kim; Jean-Philippe Antignac; Bruno Le Bizec; Karine Clément; Linda S Birnbaum; Robert Barouki
Journal:  Environ Health Perspect       Date:  2012-12-05       Impact factor: 9.031

Review 9.  Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.

Authors:  Natalie L Trevaskis; William N Charman; Christopher J H Porter
Journal:  Adv Drug Deliv Rev       Date:  2007-11-07       Impact factor: 15.470

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.